Abstract
Literature reports describe the potential for increased incidence of vaginal vault dehiscence after minimally invasive surgery, and incidental reports of vaginal vault dehiscence with vaginal vault brachytherapy. This review explores the risk of increased vaginal complications in a setting of greater use of both minimally invasive surgical techniques and adjuvant vaginal vault brachytherapy in early endometrial cancer. The impact of associated patient-related and tumor-related risk factors on clinical decision making is evaluated in selecting therapy that provides optimal tumor control while minimizing treatment adverse effects.
MeSH terms
-
Brachytherapy / adverse effects*
-
Brachytherapy / statistics & numerical data*
-
Carcinoma / epidemiology
-
Carcinoma / radiotherapy
-
Carcinoma / surgery
-
Female
-
Gynecologic Surgical Procedures / adverse effects
-
Gynecologic Surgical Procedures / statistics & numerical data
-
Humans
-
Incidence
-
Pelvic Organ Prolapse / epidemiology
-
Pelvic Organ Prolapse / etiology
-
Postoperative Complications / epidemiology
-
Surgical Wound Dehiscence / epidemiology
-
Surgical Wound Dehiscence / etiology*
-
Surgical Wound Dehiscence / prevention & control
-
Uterine Neoplasms / epidemiology
-
Uterine Neoplasms / radiotherapy
-
Uterine Neoplasms / surgery
-
Vagina / pathology*
-
Vagina / radiation effects
-
Vagina / surgery